Clinical trial
Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.
NCT07384598 is registered in ClinicalTrials.gov with Clinique Saint Pierre Ottignies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.
- Lead sponsor
- Clinique Saint Pierre Ottignies
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, intensive care (icu), thromboprophylaxis